ASRT

1.20% 0.0099

Vorhandelsmarkt: .84 0.0028 +0.33%

Assertio Holdings Inc (ASRT)

Überblick Nachrichten Preisverlauf Optionskette Financials Warum fällt ASRT? Forum Prognose Aktiensplit

Schlusskurs vom Vortag:

24-Stunden-Volumen:

Relative Volume:

Marktkapitalisierung:

Nettoeinkommen (Verlust:

Netto-Cashflow:

1W Leistung:

1M Leistung:

6M Leistung:

1J Leistung:

1-Tages-Spanne:

1-Wochen-Bereich:

52-Wochen-Spanne:

Assertio Holdings Inc Stock (ASRT) Company Profile

Assertio Holdings Inc

Healthcare (1176)

(224) 419-7106

100 S. SAUNDERS ROAD, LAKE FOREST, IL

Nächster Verdiensttermin

Neueste SEC-Einreichungen

ASRT's Discussions on Twitter

Vergleichen Sie ASRT mit anderen Aktien

Aktien	Preis	Marktkapitalisierung	Umsatz	Nettogewinn	Free Cashflow	ENV
ASRT Assertio Holdings Inc	0.8372	79.93M	169.43M	-186.01M	70.07M	-2.02
ZTS Zoetis Inc	167.53	75.58B	9.15B	2.43B	2.31B	5.32
HLN Haleon Plc Adr	9.24	41.78B	14.26B	1.55B	0	0.3383
TAK Takeda Pharmaceutical Co Adr	13.10	41.53B	30.27B	1.93B	3.45B	0.6044
TEVA Teva Pharmaceutical Industries Ltd Adr	21.82	24.72B	16.77B	-959.00M	1.37B	-0.85
NBIX Neurocrine Biosciences Inc	145.88	14.77B	2.24B	385.90M	440.10M	3.73

Assertio Holdings Inc Stock (ASRT) Upgrades & Downgrades

Datum	Aktion	Analytiker	Ratingänderung
2024-07-26	Eingeleitet	Maxim Group	Buy
2024-07-03	Eingeleitet	H.C. Wainwright	Buy
2022-11-07	Eingeleitet	Lake Street	Buy
2018-11-30	Herabstufung	Mizuho	Buy → Neutral

Assertio Holdings Inc Aktie (ASRT) Neueste Nachrichten

Finanzdaten der Assertio Holdings Inc-Aktie (ASRT)

Assertio Holdings Inc-Aktie (ASRT) Insiderhandel

Insiderhandel	Beziehung	Datum	Transaktion	Kosten	#Aktien	Wert ($)	#Aktien Gesamt
O'Grady Brendan P.	CEO	Nov 14 '24	Buy	0.85	11,706	9,950	11,706
Schlessinger Sam	SVP, General Counsel	Oct 01 '24	Option Exercise	0.00	19,404	0	141,459
Vacirca Jeff L	Director	Jun 11 '24	Buy	1.11	10,000	11,100	151,159
Mason Heather L	Interim Executive Officer	Jun 05 '24	Buy	0.97	25,000	24,250	212,650
Schlessinger Sam	SVP, General Counsel	May 12 '24	Option Exercise	0.00	38,017	0	138,895
Schwichtenberg Paul	SVP, CCO	May 12 '24	Option Exercise	0.00	38,017	0	141,941
Patel Ajay	SVP and CFO	May 12 '24	Option Exercise	0.00	38,017	0	171,271
Tyree James L	Director	Mar 14 '24	Sale	1.12	10,251	11,463	188,251
Schlessinger Sam	SVP, General Counsel	Feb 21 '24	Option Exercise	0.00	17,151	0	109,384
Schwichtenberg Paul	SVP, CCO	Feb 21 '24	Option Exercise	0.00	17,151	0	112,430

Assertio Holdings Inc (ASRT)

Assertio Holdings Inc Stock (ASRT) Company Profile

Vergleichen Sie ASRT mit anderen Aktien

Assertio Holdings Inc Stock (ASRT) Upgrades & Downgrades

Assertio Holdings Inc Aktie (ASRT) Neueste Nachrichten

Assertio Holdings, Inc. (NASDAQ:ASRT) Sees Significant Decrease in Short Interest - MarketBeat

Jane Street Group LLC Sells 277,889 Shares of Assertio Holdings, Inc. (NASDAQ:ASRT) - Defense World

Geode Capital Management LLC Purchases 42,750 Shares of Assertio Holdings, Inc. (NASDAQ:ASRT) - Defense World

Assertio Holdings, Inc. Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4) - The Manila Times

Assertio Holdings Names New Chief Commercial Officer, Awards Major Stock Incentive Package - StockTitan

Class Action Alert: Wolf Haldenstein Adler Freeman & Herz LLP reminds investors that a securities class action lawsuit has been filed in the United States District Court for the Northern District of Illinois against Assertio Holdings, Inc. - AccessWire

Assertio Holdings, Inc. (NASDAQ:ASRT) Short Interest Up 14.1% in December - MarketBeat

Is Assertio Holdings (NASDAQ:ASRT) A Risky Investment? - Simply Wall St

Assertio appoints new independent director to board By Investing.com - Investing.com South Africa

Assertio appoints new independent director to board - Investing.com

Assertio Holdings, Inc. Appoints Mark Reisenauer to Its Board of Directors - The Manila Times

Assertio Holdings Taps Former Astellas President Who Led $5B Sales Growth to Join Board - StockTitan

Assertio’s (ASRT) “Buy” Rating Reaffirmed at HC Wainwright - Defense World

Assertio Therapeutics shares get buy rating on clinical trial results By Investing.com - Investing.com Canada

Assertio (NASDAQ:ASRT) Receives Buy Rating from HC Wainwright - MarketBeat

Assertio Holdings, Inc. (NASDAQ:ASRT) Short Interest Down 11.5% in November - MarketBeat

Assertio reports positive Rolvedon trial results for breast cancer By Investing.com - Investing.com Australia

Assertio Announces Results of Rolvedon (Eflapegrastim-Xnst) Injection Same-Day Dosing Clinical Study - Marketscreener.com

Assertio reports positive Rolvedon trial results for breast cancer - Investing.com

Assertio Announces Results of Rolvedon® (eflapegrastim-xnst) injection Same-Day Dosing Clinical Study - The Manila Times

Assertio Holdings, Inc. Appoints Paul Schwichtenberg to New CTO Role, Mary Pietryga as CCO - The Manila Times

Assertio Holdings Creates Transformation Office, Appoints New Leadership to Drive Growth Strategy - StockTitan

Assertio Holdings Inc (NASDAQ: ASRT): Blank Check On Growth? - Stocks Register

Beam Therapeutics Announces Appointment of Sravan Emany as Chief Financial Officer - GlobeNewswire Inc.

Beam Therapeutics names Sravan K. Emany as new CFO - Investing.com

HC Wainwright Forecasts Stronger Earnings for Assertio - MarketBeat

Assertio shares hold price target, buy rating on stable Indocin share By Investing.com - Investing.com Canada

Assertio Holdings, Inc. (NASDAQ:ASRT) Shares Acquired by Empowered Funds LLC - Defense World

Assertio Holdings Q3 2024 Earnings Preview - MSN

Assertio stock gains amid Q3 earnings, clash with activist investor - MSN

Insider Buying: Assertio Holdings, Inc. (NASDAQ:ASRT) Director Acquires $60,000.00 in Stock - MarketBeat

Assertio Holdings director Heather Mason buys $60,000 in shares By Investing.com - Investing.com Nigeria

Assertio Holdings director Heather Mason buys $60,000 in shares - Investing.com

Assertio Holdings CEO Brendan O'Grady buys $9,950 in common stock - Investing.com India

Spectrum Pharma Faces Senate Probe Call Over Alleged Rolvedon Data Fraud | ASRT Stock News - StockTitan

Assertio Holdings Inc (ASRT) Quarterly 10-Q Report - Quartz

Assertio Holdings Third Quarter 2024 Earnings: Beats Expectations - Simply Wall St

Assertio Holdings, Inc. (NASDAQ:ASRT) Q3 2024 Earnings Call Transcript - Insider Monkey

Assertio Reports Third Quarter 2024 Financial Results - The Manila Times

Assertio: Q3 Earnings Snapshot - The Washington Post

Assertio Therapeutics’ Q3 2024 Earnings Overview - TipRanks

Assertio stock gains amid Q3 earnings, clash with activist investor (NASDAQ:ASRT) - Seeking Alpha

Assertio (ASRT) Reports Q3 Loss, Lags Revenue Estimates - Yahoo Finance

Assertio Holdings, Inc. Announces Board Changes - Marketscreener.com

Assertio Holdings Faces SEC Whistleblower Complaint Over Alleged Clinical Data Fraud | ASRT Stock News - StockTitan

Assertio Provides Response to Letter from Short-seller - GlobeNewswire

Assertio Holdings CEO Fires Back at Short-Seller's 'Baseless' Rolvedon Claims | ASRT Stock News - StockTitan

Assertio Holdings (NASDAQ:ASRT investor five-year losses grow to 72% as the stock sheds US$17m this past week - Simply Wall St

Finanzdaten der Assertio Holdings Inc-Aktie (ASRT)

Umsatz

Nettogewinn

Free Cashflow

ENV

Assertio Holdings Inc-Aktie (ASRT) Insiderhandel

Ähnlich wie ASRT